Chemotherapy Near the End of Life in Onco-Hematological Adult Patients.

Marina Sánchez CuervoLorena García-BasasEsther Gómez de Salazar-López de SilanesCristina Pueyo-LópezTeresa Bermejo-Vicedo

Published in: The American journal of hospice & palliative care (2020)

The proportion of patients receiving chemotherapy in the last 14 days of life was high, as well as the proportion of patients starting a new regimen in their last 30 days. This was indicative of excessive aggressiveness at the end-of-life care.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
locally advanced
peritoneal dialysis
prognostic factors
patient reported outcomes
weight loss